The link between diabetes and atrial fibrillation:cause or correlation

Journal of Cardiovascular Disease Research

Volumn 1, Issue 1, 2010, Pages 9-11

  Sun, Yihong ^a   Hu, Dayi ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; GLUCOSE TOLERANCE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; INFLAMMATION; INSULIN RESISTANCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE;

EID: 79953065822     PISSN: 09753583     EISSN: 09762833     Source Type: Journal    
DOI: 10.4103/0975-3583.59978     Document Type: Review

References (32)

1. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults:national implications for rhythm management and stroke prevention:the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-5. (Pubitemid 32424106)
2. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994;271:840-4.
3. Murphy NF, Simpson CR, Jhund PS, et al. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland Heart. 2007;93:606-12.
4. Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol. 2005 Dec 7;105:315-8. (Pubitemid 41605083)
5. Iguchi Y, Kimura K, Aoki J, et al. Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan:analysis of 41,436 non-employee residents in Kurashiki-city. Circ J. 2008 Jun;72:909-13.
6. Zhou Z, Hu D. An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China. J Epidemiol. 2008;18:209-16.
7. Schnabel RB, Sullivan LM, Levy D, et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): A community-based cohort study. Lancet. 2009;373:739-45.
8. Nichols GA, Reinier K, Chugh SS. Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. Diabetes Care. 2009;32:1851-6.
9. Haywood LJ, Ford CE, Crow RS,, et al. ALLHAT Collaborative Research Group. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). J Am Coll Cardiol. 2009;54:2023-31.
10. Aksnes TA, Schmieder RE, Kjeldsen SE, et al. Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in highrisk hypertension (from the VALUE Trial). Am J Cardiol. 2008;101:634-8. (Pubitemid 351625088)
11. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, et al. C-reactive protein elevation in patients with atrial arrhythmias:inflammatory mechanisms and persistence of atrial fibrillations. Circulation 2001;104:2886-91. (Pubitemid 33139098)
12. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96:1180-4. (Pubitemid 27344221)
13. Rutter MK, Parise H, Benjamin EJ, et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function:sex-related differences in the Framingham Heart Study. Circulation. 2003;107:448-54. (Pubitemid 36158048)
14. Schmid H, Forman LA, Cao X, et al. Heterogeneous cardiac sympathetic denervation and decreased myocardial nerve growth factor in streptozotocin induced diabetic rats:implications for cardiac sympathetic dysinnervation complicating diabetes. Diabetes. 1999;48:603-8. (Pubitemid 29106876)
15. Olgin JE, Sih HJ, Hanish S, et al. Heterogeneous atrial denervation creates substrate for sustained atrial fibrillation. Circulation. 1998;98:2608-14. (Pubitemid 29001202)
16. Benjamin EJ, Chen PS, Bild DE, et al. Prevention of atrial fibrillation:report from a national heart, lung, and blood institute workshop. Circulation. 2009;119:606-18.
17. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults:national implications for rhythm management and stroke prevention:the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-5. (Pubitemid 32424106)
18. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994;271:840-4.
19. Murphy NF, Simpson CR, Jhund PS, et al. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart. 2007;93:606-12. (Pubitemid 46722325)
20. Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol. 2005 Dec 7;105:315-8. (Pubitemid 41605083)
21. Iguchi Y, Kimura K, Aoki J, et al. Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan:analysis of 41,436 non-employee residents in Kurashiki-city. Circ J. 2008 Jun;72:909-13. (Pubitemid 351879910)
22. Zhou Z, Hu D. An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China. J Epidemiol. 2008;18:209-16.
23. Schnabel RB, Sullivan LM, Levy D, et al. Development of a risk score for atrial fibrillation (Framingham Heart Study):a community-based cohort study. Lancet. 2009;373:739-45.
24. Nichols GA, Reinier K, Chugh SS. Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. Diabetes Care. 2009 ;32:1851-6.
25. Haywood LJ, Ford CE, Crow RS, ;ALLHAT Collaborative Research Group. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart AttackTrial). J Am Coll Cardiol. 2009;54:2023-31.
26. Aksnes TA, Schmieder RE, Kjeldsen SE, et al. Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in highrisk hypertension (from the VALUE Trial). Am J Cardiol. 2008;101:634-8. (Pubitemid 351625088)
27. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA C-reactive protein elevation in patients with atrial arrhythmias:inflammatory mechanisms and persistence of atrial fibrillations. Circulation, 2001;104:2886-91. (Pubitemid 33139098)
28. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96:1180-4. (Pubitemid 27344221)
29. Rutter MK, Parise H, Benjamin EJ, et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function:sex-related differences in the Framingham Heart Study. Circulation. 2003;107:448-54. (Pubitemid 36158048)
30. Schmid H, Forman LA, Cao X, et al. Heterogeneous cardiac sympathetic denervation and decreased myocardial nerve growth factor in streptozotocin- induced diabetic rats:implications for cardiac sympathetic dysinnervation complicating diabetes. Diabetes. 1999;48:603-8. (Pubitemid 29106876)
31. Olgin JE, Sih HJ, Hanish S, et al. Heterogeneous atrial denervation creates substrate for sustained atrial fibrillation. Circulation. 1998;98:2608-14. (Pubitemid 29001202)
32. Benjamin EJ, Chen PS, Bild DE, et al. Prevention of atrial fibrillation:report from a national heart, lung, and blood institute workshop. Circulation. 2009;119:606-18.